Trial intelligence / Profile preview

Rapamune vs Betamethasone in Chronic Erosive Oral Lichen Planus

NCT01061853Phase 3Terminated

Sponsor
University Hospital Tours
Start
Feb 2008
Primary completion
Nov 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of sirolimus in oral lichen planus (OLP), sponsored by University Hospital Tours. Started Feb 2008; status: terminated.

02

Drugs

sirolimus
03

Conditions

oral lichen planus (OLP)

Beyond the preview

Go deeper on NCT01061853.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01061853.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call